2025, Volume 32, Issue 3

Targeting Obesity in PCOS: A Review of Current Pharmacological Interventions and Future Directions

Obesity is a common and significant comorbidity of Polycystic Ovary Syndrome (PCOS), contributing to a range of metabolic and reproductive complications. The rising prevalence of obesity, particularly among women of reproductive age, exacerbates the symptoms of PCOS, such as Insulin […]

Read More… from Targeting Obesity in PCOS: A Review of Current Pharmacological Interventions and Future Directions

Read More »

Structural and Molecular Insights into AipA and OmpA: Key Drivers of Anaplasma phagocytophilum Host Cell Invasion

Background: This analysis investigates invasion tactics of Anaplasma phagocytophilum which constitutes a gram-negative bacterial species that causes the tick-borne pathogen known as human granulocytic anaplasmosis (HGA).Aim: This study analyzes structural and molecular dynamic aspects of invasion proteins AipA and OmpA […]

Read More… from Structural and Molecular Insights into AipA and OmpA: Key Drivers of Anaplasma phagocytophilum Host Cell Invasion

Read More »

Evaluating AFC and Hormonal Profiles in Infertility: Insights into PCOS Diagnosis in Samawa City, Iraq

Background: Polycystic ovary syndrome (PCOS) is the single most common endocrine-metabolic disorder among reproductive-aged women, characterized by hyperandrogenism (HA), ovulatory dysfunction (IM), and polycystic ovarian morphology (PCO). The antral follicle count (AFC) has been widely used as a diagnostic marker […]

Read More… from Evaluating AFC and Hormonal Profiles in Infertility: Insights into PCOS Diagnosis in Samawa City, Iraq

Read More »

Impact of Sitagliptin on Inflammatory Biomarkers in Type 2 Diabetes Mellitus

Background: Type 2 diabetes mellitus (T2DM) is associated with low-grade inflammatory response, which was reported to contribute to insulin resistance. Sitagliptin, a dipeptidyl peptidase-4 (DPP-4) inhibitor, is widely used for glycemic control and has been suggested to exert anti-inflammatory effects.Aims: […]

Read More… from Impact of Sitagliptin on Inflammatory Biomarkers in Type 2 Diabetes Mellitus

Read More »

ISSN-online 2360-2473
ISSN-L 1223-0472
ISSN-print 1223-0472

Indexing

The Modern Medicine / Medicina Moderna is indexed by:

SCOPUS, with CiteScoreTracker 2024 = 0.8

Scimago Journal Rank SJR = 0,192 in 2024

DOAJ

Google Scholar with h-index (all) = 7

Sciencegate

Researcher life

CME Credits: 10
(Romanian College of Physicians) 

Licence

Skip to content